October 8th 2021

Repurposing efforts concluded

Repurposing efforts conducted

The partners of the CARE consortium conducted a high throughput screening (HTS), or testing, of approximately 20,000 approved or clinically validated compounds as part of its emergency response track (pillar 1 of the research programme). The CARE research teams identified several single digit µM compounds. However, none of these were deemed beneficial for repurposing, as the identified compounds were either similar to those identified by other groups or were inappropriate for further development. The CARE consortium will consider the findings in its efforts for future pandemic preparedness (pillars 2 and 3 of the research programme) and insights gained in the other research pillars will support the emergency response moving forward.